| DC Field | Value | Language |
|---|
| dc.contributor.author | Lambuk, L. | - |
| dc.contributor.author | Lezhitsa, I. | - |
| dc.contributor.author | Renu Agarwal | - |
| dc.contributor.author | Peresypkina, A. | - |
| dc.contributor.author | Pobeda, A. | - |
| dc.date.accessioned | 2023-03-02T09:08:49Z | - |
| dc.date.available | 2023-03-02T09:08:49Z | - |
| dc.date.issued | 2021 | - |
| dc.identifier.citation | Magnesium acetyltaurate prevents retinal damage and visual impairment in rats through suppression of NMDA-induced upregulation of NF-κB, p53 and AP-1 (c-Jun/c-Fos) / L. Lambuk [et al.] // Neural Regeneration Research. - 2021. - Vol.16, №11.-P. 2330-2334. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/51969 | - |
| dc.description.abstract | Magnesium acetyltaurate (MgAT) has been shown to have a protective effect against N-methyl-D-aspartate (NMDA)-induced retinal cell apoptosis. The current study investigated the involvement of nuclear factor kappa-B (NF-κB), p53 and AP-1 family members (c-Jun/c-Fos) in neuroprotection by MgAT against NMDA-induced retinal damage | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | ophthalmology | ru |
| dc.subject | pharmacology | ru |
| dc.subject | AP-1 (c-Jun/c-Fos) | ru |
| dc.subject | electroretinography | ru |
| dc.subject | magnesium acetyltaurate | ru |
| dc.subject | neuroprotection | ru |
| dc.subject | NF-κB | ru |
| dc.subject | N-methyl-D-aspartate | ru |
| dc.subject | retinal excitotoxicity | ru |
| dc.subject | retrograde labelling | ru |
| dc.title | Magnesium acetyltaurate prevents retinal damage and visual impairment in rats through suppression of NMDA-induced upregulation of NF-κB, p53 and AP-1 (c-Jun/c-Fos) | ru |
| dc.type | Article | ru |
| Appears in Collections: | Статьи из периодических изданий и сборников (на иностранных языках) = Articles from periodicals and collections (in foreign languages)
|
